Zai Lab (ZLAB) Income from Continuing Operations (2020 - 2026)
Zai Lab's (ZLAB) quarterly Income from Continuing Operations came in at 51016000.0 in Q1 2026, down 5.32% year-on-year from 53883842.3 in Q1 2025, and down 1.2% quarter-over-quarter from 50409000.0 in Q4 2025.
Zai Lab (ZLAB) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Zai Lab has disclosed Income from Continuing Operations across 7 years of filings, most recently posting 51016000.0 for Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 51016000.0, down 5.32% year-over-year; the trailing twelve-month figure through Mar 2026 was 178115000.0 (up 29.34% YoY), and the FY2025 annual result was 175537000.0, up 31.73% from the prior year.
- Income from Continuing Operations came in at 51016000.0 for Q1 2026 at Zai Lab, down from 50409000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 35963000.0 in Q3 2025 to a low of 161190000.0 in Q3 2022.
- The 5-year median for Income from Continuing Operations is 61769000.0 (2022), against an average of 74196529.41.
- Peak annual rise in Income from Continuing Operations reached 70.77% in 2022, while the deepest fall reached 67.78% in 2022.
- Zai Lab's Income from Continuing Operations stood at 61769000.0 in 2022, then plunged by 54.49% to 95429000.0 in 2023, then climbed by 14.4% to 81684000.0 in 2024, then soared by 38.29% to 50409000.0 in 2025, then slipped by 1.2% to 51016000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 51016000.0 (Q1 2026), 50409000.0 (Q4 2025), and 35963000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.80 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.40 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | -51.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.02 Mn |
| Dec 31, 2025 | -50.41 Mn |
| Sep 30, 2025 | -35.96 Mn |
| Jun 30, 2025 | -40.73 Mn |
| Mar 31, 2025 | -48.44 Mn |
| Dec 31, 2024 | -81.68 Mn |
| Sep 30, 2024 | -41.67 Mn |
| Jun 30, 2024 | -80.28 Mn |
| Mar 31, 2024 | -53.47 Mn |
| Dec 31, 2023 | -95.43 Mn |
| Sep 30, 2023 | -69.15 Mn |
| Jun 30, 2023 | -120.90 Mn |
| Mar 31, 2023 | -49.14 Mn |
| Dec 31, 2022 | -61.77 Mn |
| Sep 30, 2022 | -161.19 Mn |
| Jun 30, 2022 | -137.93 Mn |
| Mar 31, 2022 | -82.17 Mn |
| Dec 31, 2021 | -211.32 Mn |
| Sep 30, 2021 | -96.07 Mn |
| Jun 30, 2021 | -162.92 Mn |